The multiplicity threats coming from technological based systems continues to rise as the dawn of the fourth industrial revolution. Contemporary society… Lire la suite How Artificial Intelligence is changing the future of German Army
AI in the taxation domain consists of a wide variety of narrowly and sharply defined tools for particular tasks. In this section,… Lire la suite How Artificial Intelligence is entering the world of tax
Disparities in healthcare access still persist. Almost 15 years after Morocco’s major healthcare reforms aimed at reducing health inequalities across… Lire la suite The developing moroccan healthcare sector will create opportunity In the regional Pharmaceutical Market
Eli Lilly and Loxo Oncology have entered into a definitive agreement for Lilly to acquire Loxo Oncology for USD235.00 per share in cash,… Lire la suite Lilly’s Oncology Ambitions, Loxo Acquisition is a perfect portfolio match
Novartis has offered to acquire CellforCure in order to expand its manufacturing capacity for innovative cell and gene therapies. The proposed acquisition builds… Lire la suite CAR-T cells, an industrial challenge for Novartis oncology
Founded in 1896, Switzerland-based Roche has two core businesses – pharmaceuticals and diagnostics. The firm employs over 80,000 people and markets its… Lire la suite Innovation, breakthrough therapies, Focus on the Roche oncology strategy
Historically enshrined as the inventor of aspirin, Bayer is a diversified, scientifically-focused company with core competencies in the fields of healthcare and… Lire la suite Monsanto acquisition, Pharmaceutical innovation, focus on the Bayer group evolving strategy
A wide range of cancer drug technology was showcased at the 2018 European Society for Medical Oncology (ESMO) Congress. PD-1 inhibitors… Lire la suite European Society for Medical Oncology (ESMO) 2018, is all therapies will be immuno-oncology ?